Presynaptic inhibition of nigrostriatal dopamine release in the mouse: Lack of cross tolerance between apomorphine, GBL and CGS 10746B

This publication has 19 references indexed in Scilit:

• Dopamine autoreceptor agonists including CGS 15855A decrease dopamine release and metabolism in mouse brain
  European Journal of Pharmacology, 1987
• CGS 10746B: An atypical antipsychotic candidate that selectively decreases dopamine release at behaviorally effective doses
  Life Sciences, 1986
• Effects of Neurotransmitters or Drugs on the in Vivo Release of Dopamine and Its Metabolites
  The Japanese Journal of Pharmacology, 1986
• Effect of neuroleptic drugs on striatal dopamine release and metabolism in the awake rat studied by intracerebral dialysis
  European Journal of Pharmacology, 1984
• Trans-striatal dialysis coupled to reverse phase high performance liquid chromatography with electrochemical detection: a new method for the study of the in vivo release of endogenous dopamine and metabolites
  Journal of Neuroscience, 1984
• Benzodiazepines and gabaergic regulation of nigrostriatal neurons: Lack of tolerance
  Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1984
• Differential actions of classical and atypical neuroleptics on mouse nigrostriatal neurons
  Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1983
• Cross-tolerance of dopamine metabolism to baclofen, γ-butyrolactone and HA-966 in the striatum and olfactory tubercle of the rat
  Life Sciences, 1981
• 3-methoxytyramine: Its suitability as an indicator of synaptic dopamine release
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1981
• Significance of dopamine metabolites in the evaluation of drugs acting on dopaminergic neurones
  European Journal of Pharmacology, 1978